Published in Lab Invest on December 01, 1995
Quantitative analysis of herpes simplex virus reactivation in vivo demonstrates that reactivation in the nervous system is not inhibited at early times postinoculation. J Virol (2003) 1.20
Oral inoculation with herpes simplex virus type 1 infects enteric neuron and mucosal nerve fibers within the gastrointestinal tract in mice. J Virol (1996) 1.00
Timed appearance of lymphocytic choriomeningitis virus after gastric inoculation of mice. Am J Pathol (1997) 0.96
Latent herpes simplex virus type 1 gene expression in ganglia innervating the human gastrointestinal tract. J Virol (1997) 0.86
Tumor-related dysmotility: gastrointestinal dysmotility syndromes associated with tumors. Dig Dis Sci (1998) 0.79
Adenosine-mediated enteric neuromuscular function is affected during herpes simplex virus type 1 infection of rat enteric nervous system. PLoS One (2013) 0.79
Herpes simplex virus type 1 in peptic ulcer disease: an inverse association with Helicobacter pylori. World J Gastroenterol (2005) 0.76
The role of Herpes simplex and Helicobacter pylori infection in the etiology of persistent or recurrent gastric erosions: a follow-up study. Dig Dis Sci (2002) 0.75
Detection of herpes simplex virus type 1 transcripts during latent infection in mice. J Virol (1987) 5.12
RNA from an immediate early region of the type 1 herpes simplex virus genome is present in the trigeminal ganglia of latently infected mice. Proc Natl Acad Sci U S A (1987) 4.98
Detection of HSV-1 genome in central nervous system of latently infected mice. Nature (1983) 3.95
Localization of herpes simplex virus in the trigeminal and olfactory systems of the mouse central nervous system during acute and latent infections by in situ hybridization. Lab Invest (1984) 3.67
Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection. EMBO J (1989) 3.65
Retracted Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature (2006) 3.47
During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure. J Virol (1989) 3.29
Early Ad-2 transcription units: only promoter-proximal RNA continues to be made in the presence of DRB. Virology (1979) 3.06
Expression of herpes simplex virus type 1 latency-associated transcripts in the trigeminal ganglia of mice during acute infection and reactivation of latent infection. J Virol (1988) 2.80
In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye model. J Virol (1991) 2.54
Latent herpes simplex virus type 1 transcripts in peripheral and central nervous system tissues of mice map to similar regions of the viral genome. J Virol (1988) 2.46
Herpes simplex type 1 DNA in human brain tissue. Proc Natl Acad Sci U S A (1981) 2.45
Mapping of low abundance latency-associated RNA in the trigeminal ganglia of mice latently infected with herpes simplex virus type 1. J Gen Virol (1990) 2.25
Mapping of RNA initiation sites by high doses of uv irradiation: evidence for three independent promoters within the left 11% of the Ad-2 genome. Virology (1979) 2.22
Physical state of the latent herpes simplex virus genome in a mouse model system: evidence suggesting an episomal state. Virology (1987) 2.05
The major late adenovirus type-2 transcription unit: termination is downstream from the last poly(A) site. J Mol Biol (1979) 2.04
Latent herpes simplex virus type 1 transcription in human trigeminal ganglia. J Virol (1988) 2.02
DRB-induced premature termination of late adenovirus transcription. Nature (1978) 1.98
Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal ganglia. Virology (1996) 1.96
Multiple discrete sites for premature RNA chain termination late in adenovirus-2 infection: enhancement by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole. Proc Natl Acad Sci U S A (1979) 1.92
Latent herpes simplex virus type 1 DNA contains two copies of the virion DNA joint region. J Virol (1985) 1.90
Gene expression during reactivation of herpes simplex virus type 1 from latency in the peripheral nervous system is different from that during lytic infection of tissue cultures. J Virol (1997) 1.86
During lytic infection herpes simplex virus type 1 is associated with histones bearing modifications that correlate with active transcription. J Virol (2004) 1.84
A herpes simplex virus type 1 latency-associated transcript mutant reactivates with normal kinetics from latent infection. J Virol (1990) 1.83
Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: report of consensus workshop. J Pediatr Gastroenterol Nutr (1997) 1.79
In situ DNA PCR and RNA hybridization detection of herpes simplex virus sequences in trigeminal ganglia of latently infected mice. Virology (1995) 1.77
An HSV LAT null mutant reactivates slowly from latent infection and makes small plaques on CV-1 monolayers. Virology (1993) 1.69
Brain stem localization of rodent esophageal premotor neurons revealed by transneuronal passage of pseudorabies virus. Gastroenterology (1994) 1.49
Development of a syngenic murine B16 cell line-derived melanoma susceptible to destruction by neuroattenuated HSV-1. Mol Ther (2001) 1.47
Role of the diaphragm in the genesis of lower esophageal sphincter pressure in the cat. Gastroenterology (1985) 1.44
Chromosomal organization of the herpes simplex virus genome during acute infection of the mouse central nervous system. J Virol (1986) 1.41
Acremonium infection of the esophagus. J Pediatr Gastroenterol Nutr (1997) 1.39
Characterization of herpes simplex virus type 2 transcription during latent infection of mouse trigeminal ganglia. J Virol (1990) 1.34
The herpes simplex virus type 1 2.0-kilobase latency-associated transcript is a stable intron which branches at a guanosine. J Virol (1997) 1.33
Induction of cellular transcription factors in trigeminal ganglia of mice by corneal scarification, herpes simplex virus type 1 infection, and explantation of trigeminal ganglia. J Virol (1991) 1.24
A herpes simplex virus type 1 variant, deleted in the promoter region of the latency-associated transcripts, does not produce any detectable minor RNA species during latency in the mouse trigeminal ganglion. J Gen Virol (1990) 1.23
Novobiocin and coumermycin A1 inhibit viral replication and the reactivation of herpes simplex virus type 1 from the trigeminal ganglia of latently infected mice. J Virol (1987) 1.23
Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivation. Microb Pathog (1993) 1.21
The replicating intermediates of herpes simplex virus type 1 DNA are relatively short. J Neurovirol (1995) 1.21
Herpesvirus vector gene transfer and expression of beta-glucuronidase in the central nervous system of MPS VII mice. Nat Genet (1992) 1.21
Investigation of herpes simplex virus type 1 (HSV-1) gene expression and DNA synthesis during the establishment of latent infection by an HSV-1 mutant, in1814, that does not replicate in mouse trigeminal ganglia. J Gen Virol (1991) 1.21
CpG frequency in large DNA segments. J Mol Evol (1983) 1.20
Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection. Infect Immun (2000) 1.18
T1rho imaging of murine brain tumors at 4 T. Acad Radiol (2001) 1.17
Analysis of a herpes simplex virus type 1 LAT mutant with a deletion between the putative promoter and the 5' end of the 2.0-kilobase transcript. J Virol (1994) 1.17
The herpes simplex virus type 1 strain 17+ gamma 34.5 deletion mutant 1716 is avirulent in SCID mice. J Gen Virol (1994) 1.15
Egg proteins in cod serum. Natural occurrence and induction by injections of oestradiol 3-benzoate. Biochem J (1971) 1.15
A herpes simplex virus type 1 mutant with a deletion immediately upstream of the LAT locus establishes latency and reactivates from latently infected mice with normal kinetics. J Neurovirol (1996) 1.13
Mechanisms for the association of gastroesophageal reflux and bronchospasm. Am Rev Respir Dis (1985) 1.11
Herpes simplex virus type 1 latency-associated transcript (LAT) promoter deletion mutants can express a 2-kilobase transcript mapping to the LAT region. J Virol (1993) 1.11
The transcriptional activation domain of VP16 is required for efficient infection and establishment of latency by HSV-1 in the murine peripheral and central nervous systems. Virology (1999) 1.10
Latent herpes simplex virus type 1 DNA is not extensively methylated in vivo. J Gen Virol (1987) 1.08
An HSV-1 mutant lacking the LAT TATA element reactivates normally in explant cocultivation. Virology (1993) 1.07
Herpes simplex virus type 1 mutant strain in1814 establishes a unique, slowly progressing infection in SCID mice. J Virol (1992) 1.05
Therapy of experimental human brain tumors using a neuroattenuated herpes simplex virus mutant. Lab Invest (1995) 1.05
Replication, establishment of latent infection, expression of the latency-associated transcripts and explant reactivation of herpes simplex virus type 1 gamma 34.5 mutants in a mouse eye model. J Gen Virol (1995) 1.04
Poly(A) sites of adenovirus serotype 2 transcription units. J Mol Biol (1982) 1.04
A review of the molecular mechanism of HSV-1 latency. Curr Eye Res (1991) 1.03
The HSV-1 2-kb latency-associated transcript is found in the cytoplasm comigrating with ribosomal subunits during productive infection. Virology (1994) 1.02
Incorporation of l-[C]leucine into egg proteins by liver slices from cod. Biochem J (1971) 1.02
Cystic fibrosis transmembrane conductance regulator expression in human hypothalamus. Neuroreport (1998) 1.01
A thymidine kinase-negative HSV-1 strain establishes a persistent infection in SCID mice that features uncontrolled peripheral replication but only marginal nervous system involvement. Virology (1994) 1.01
Gadusol, an enolic derivative of cyclohexane-1,3-dione present in the roes of cod and other marine fish. Isolation, properties and occurrence compared with ascorbic acid. Biochem J (1981) 1.00
Herpes simplex virus type 1 gene expression and reactivation of latent infection in the central nervous system. Neuropathol Appl Neurobiol (1994) 0.99
Role of the immune response during neuro-attenuated herpes simplex virus-mediated tumor destruction in a murine intracranial melanoma model. Cancer Res (2000) 0.99
Central integration of swallow and airway-protective reflexes. Am J Med (2000) 0.99
Use of a "replication-restricted" herpes virus to treat experimental human malignant mesothelioma. Cancer Res (1997) 0.99
Treatment of experimental intracranial murine melanoma with a neuroattenuated herpes simplex virus 1 mutant. Virology (1995) 0.98
Long term herpes simplex virus type 1 infection of nerve growth factor-treated PC12 cells. J Gen Virol (1994) 0.98
N-linked oligosaccharides on herpes simplex virus glycoprotein gD are not essential for establishment of viral latency or reactivation in the mouse eye model. Virology (1994) 0.97
Analysis of protein expression from within the region encoding the 2.0-kilobase latency-associated transcript of herpes simplex virus type 1. J Virol (2001) 0.96
Expression and localization of the cystic fibrosis transmembrane conductance regulator mRNA and its protein in rat brain. J Clin Invest (1995) 0.95
Long-term AAV vector gene and protein expression in mouse brain from a small pan-cellular promoter is similar to neural cell promoters. Gene Ther (2009) 0.95
CFTR is functionally active in GnRH-expressing GT1-7 hypothalamic neurons. Am J Physiol (1999) 0.95
Identification of a novel 0.7-kb polyadenylated transcript in the LAT promoter region of HSV-1 that is strain specific and may contribute to virulence. Virology (1999) 0.95
Repression of the HSV-1 latency-associated transcript (LAT) promoter by the early growth response (EGR) proteins: involvement of a binding site immediately downstream of the TATA box. J Neurovirol (1997) 0.94
Human corneal cells and other fibroblasts can stimulate the appearance of herpes simplex virus from quiescently infected PC12 cells. J Virol (1999) 0.94
The cellular response to herpes simplex virus type 1 (HSV-1) during latency and reactivation. J Neurovirol (2005) 0.94
Herpes simplex virus type 1 2-kilobase latency-associated transcript intron associates with ribosomal proteins and splicing factors. J Virol (2001) 0.93
Mapping of the 3' terminus of the large late ad-2 transcript by electron microscopy. Virology (1980) 0.93
Expanding the clinicopathologic spectrum of herpes simplex encephalitis. Hum Pathol (1998) 0.92
Transfectable and transplantable postmitotic human neurons: a potential "platform" for gene therapy of nervous system diseases. Exp Neurol (1997) 0.91
Brainstem viscerotopic organization of afferents and efferents involved in the control of swallowing. Am J Med (2000) 0.91
Expression of entry receptor nectin-1 of herpes simplex virus 1 and/or herpes simplex virus 2 in normal and neoplastic human nervous system tissues. Acta Virol (2006) 0.89
Oral-oesophageal inoculation of mice with herpes simplex virus type 1 causes latent infection of the vagal sensory ganglia (nodose ganglia). J Gen Virol (1994) 0.87
Simultaneous reflex inhibition of lower esophageal sphincter and crural diaphragm in cats. Am J Physiol (1985) 0.87